Stock HALO HALOZYME THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Halozyme Therapeutics, Inc.

Equities

HALO

US40637H1095

Market Closed - Nasdaq
Other stock markets
 04:00:03 2024-04-23 pm EDT 		5-day change 1st Jan Change
38.94 USD +0.59% Intraday chart for Halozyme Therapeutics, Inc. +1.46% +5.36%
Apr. 18 Halozyme Therapeutics Insider Sold Shares Worth $768,390, According to a Recent SEC Filing MT
Mar. 13 Halozyme Therapeutics Insider Sold Shares Worth $839,100, According to a Recent SEC Filing MT

Chart calendar Halozyme Therapeutics, Inc.

0632.A-Dc0cnTiQnAEMNGMuMl3R4sUHnduyGXG93zlQwWLDs.RIikjoa9uHqtc4BrRZd1uyYcGDCfy02jLI-dzTUle2JSgbDj-qveP_V8ig~a54b52057d95ab403eba3812a7d0e6b0

Upcoming events on Halozyme Therapeutics, Inc.

2024-04-25 03:00 pm Annual General Meeting
2024-05-06 Q1 2024 Earnings Release (Projected)
2024-08-05 Q2 2024 Earnings Release (Projected)
2024-11-03 Q3 2024 Earnings Release (Projected)
2025-02-24 Q4 2024 Earnings Release (Projected)

Past events on Halozyme Therapeutics, Inc.

2024-03-13 10:45 am Barclays Global Healthcare Conference
2024-03-12 03:00 pm Leerink Partners Global Biopharma Conference
2024-03-05 02:50 pm TD Cowen Health Care Conference
2024-02-20 04:30 pm Q4 2023 Earnings Call
2024-02-20 04:01 pm Q4 2023 Earnings Release
2024-01-17 08:30 am Business Update Call
2023-11-29 12:30 pm Evercore ISI HealthCONx Conference
2023-11-29 08:00 am Piper Sandler Healthcare Conference
2023-11-06 04:30 pm Q3 2023 Earnings Call
2023-11-06 04:01 pm Q3 2023 Earnings Release
2023-10-17 10:35 am Partnership Opportunities in Drug Delivery Conference
2023-09-13 01:25 pm Baird Global Healthcare Conference
2023-09-12 10:50 am Morgan Stanley Global Healthcare Conference
2023-09-11 09:30 am H.C. Wainwright Global Investment Conference
2023-09-07 08:00 am Wells Fargo Healthcare Conference
2023-08-08 04:30 pm Q2 2023 Earnings Call
2023-08-08 04:01 pm Q2 2023 Earnings Release
2023-06-13 11:00 am Goldman Sachs Global Healthcare Conference
2023-05-22 Benchmark Healthcare House Call Virtual Conference
2023-05-15 01:30 pm JMP Securities Life Sciences Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		196
197
-0.69%		268
265
0.89%		443
442
0.4%		660
672
-1.74%		829
830
-0.13%
955

EBITDA
Million USD		Released
Forecast
Spread 		-63,5
-56,4
-12.67%		148
144
2.66%		279
278
0.26%		315
339
-7.01%		426
414
3.04%
544

EBIT
Million USD		Released
Forecast
Spread 		-67,6
-60,2
-12.29%		144
148
-2.83%		276
276
-0.04%		268
286
-6.39%		338
344
-1.85%
471

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-72,3
-64,1
-12.79%		129
135
-4.33%		249
250
-0.74%		249
229
8.89%		348
349
-0.08%
468

Net income
Million USD		Released
Forecast
Spread 		-72,2
-63,8
-13.27%		129
132
-2.57%		403
392
2.8%		202
183
10.35%		282
279
0.92%
368

EPS
USD		Released
Forecast
Spread 		-0,50
-0,44
-14.43%		0,91
0,93
-2.4%		2,74
2,68
2.07%		1,44
1,32
9.33%		2,10
2,07
1.29%
2,99

Announcement Date24/02/2023/02/2122/02/2221/02/2320/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		102
99,7
2.32%		117
129
-8.74%		152
156
-2.33%		209
191
9.31%		181
192
-5.5%		162
176
-7.62%		221
200
10.55%		216
216
-0.04%		230
231
-0.48%
201


208


254


291


243

EBITDA
Million USD		Released
Forecast
Spread 		57,3
60,0
-4.49%		81,2
90,0
-9.79%		40,8


85,3
105
-18.76%		79,5
98,0
-18.93%		74,5
83,0
-10.2%		115
108
6.38%		115
119
-3.18%		122
126
-3.48%
116


112


144


190




EBIT
Million USD		Released
Forecast
Spread 		56,5
58,3
-3.11%		75,7
85,7
-11.65%		34,1
88,9
-61.68%		83,3
79,1
5.29%		74,5
65,7
13.47%		53,8
68,5
-21.44%		94,5
87,4
8.04%		88,3
94,0
-6.07%		101
109
-7.05%
89,8


92,7


135


153


145

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		54,8
55,9
-1.96%		74,4
80,5
-7.58%		30,0
88,2
-65.97%		73,7
64,5
14.36%		70,8
48,5
46.02%		52,2
57,6
-9.38%		93,2
83,7
11.26%		102
88,6
14.89%		101
104
-2.82%
91,6


91,6


133


152


141

Net income
Million USD		Released
Forecast
Spread 		66,8
55,0
21.34%		60,1
63,6
-5.52%		22,7
67,9
-66.59%		61,6
48,2
27.92%		57,7
36,0
60.34%		39,6
43,3
-8.56%		74,8
65,6
13.95%		81,8
70,5
16.03%		85,4
84,8
0.68%
71,3


71,3


106


124


113

EPS
USD		Released
Forecast
Spread 		0,46
0,38
20.26%		0,43
0,46
-6.52%		0,16
0,47
-65.59%		0,44
0,36
21.66%		0,42
0,28
49.24%		0,29
0,32
-9.85%		0,57
0,47
20.91%		0,61
0,52
18.28%		0,65
0,64
1.04%
0,58


0,60


0,85


0,98


0,94

Announcement Date22/02/2210/05/2209/08/2208/11/2221/02/2309/05/2308/08/2306/11/2320/02/24-----

Upcoming sector events for Halozyme Therapeutics, Inc.

Today 04:05 pm VIKING THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 REMEGEN CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 HITGEN INC.: Q4 2023 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Halozyme Therapeutics, Inc.

Today INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release (Projected)
Today SINOCELLTECH GROUP LIMITED: Q1 2024 Earnings Release (Projected)
Today SHANGHAI MEDICILON INC.: Q4 2023 Earnings Release
2024-04-23 07:30 am KINIKSA PHARMACEUTICALS, LTD.: Q1 2024 Earnings Release
2024-04-17 BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-17 JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release
2024-04-12 SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release
2024-04-10 07:00 am NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-09 BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q4 2023 Earnings Release
2024-04-08 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. HALO Stock
  4. Calendar Halozyme Therapeutics, Inc.